+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticonvulsants"

Krabbe Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Krabbe Disease Treatment - Global Strategic Business Report

  • Report
  • July 2026
  • 194 Pages
  • Global
From
Acute Repetitive Seizures - Global Strategic Business Report - Product Thumbnail Image

Acute Repetitive Seizures - Global Strategic Business Report

  • Report
  • July 2026
  • 180 Pages
  • Global
From
Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs - Global Strategic Business Report

  • Report
  • July 2026
  • 193 Pages
  • Global
From
From
From
From
From
From
From
From
From
Fragile X Syndrome (FXS) Treatment Market Report 2026 - Product Thumbnail Image

Fragile X Syndrome (FXS) Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Diabetic Neuropathy - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Neuropathy - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 180 Pages
  • Global
From
Diabetic Neuropathic Pain - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Postherpetic Neuralgia - Pipeline Insight, 2026 - Product Thumbnail Image

Postherpetic Neuralgia - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
From
From
Trichotillomania (TTM) Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Trichotillomania (TTM) Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Dravet Syndrome (DS) Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Dravet Syndrome (DS) Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Migraine Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Migraine Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Loading Indicator

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics. The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more